Analyst Price Target is $16.25
▲ +207.77% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Orchestra BioMed in the last 3 months. The average price target is $16.25, with a high forecast of $20.00 and a low forecast of $14.00. The average price target represents a 207.77% upside from the last price of $5.28.
Current Consensus is
Buy
The current consensus among 4 contributing investment analysts is to buy stock in Orchestra BioMed.